Active substance
Clobetasol
- SFDA 22
- US FDA 100
- Health Canada 19
- US price lines 20
- NHS prices 8
- Safety 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CLOBEDERM | 0.05 % | Cream · Topical | 1 Tube | SAR 7.55 | Generic · Prescription | RIYADH PHARMA | Valid |
| CLODERM 0.05% CREAM | 0.05 % | Cream · Topical | 1 Tube | SAR 5.95 | Generic · Prescription | UNITED PHARMACEUTICAL CO. | Valid |
| CLODERM 0.05% OINTMENT | 0.05 % | Ointment · Topical | 1 Tube | SAR 5.95 | Generic · Prescription | UNITED PHARMACEUTICAL CO. | Valid |
| DERMAMED 0.05% OINTMENT | 0.05 % | Ointment · Topical | 1 Tube | SAR 6.20 | Generic · Prescription | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Valid |
| DERMOVATE 0.05% SCALP APPLICATION | 0.05 % | Scalp solution · Topical | 1 Bottle | SAR 17.00 | NCE · Prescription | GLAXO SAUDI ARABIA | Valid |
| DERMOVATE CREAM 0.05% | 0.05 % | Cream · Topical | 1 Tube | SAR 9.45 | Generic · Prescription | GLAXO SAUDI ARABIA | Valid |
| DERMOVATE OINTMENT 0.05% | 0.05 % | Ointment · Topical | 1 Tube | SAR 9.45 | Generic · Prescription | GLAXO SAUDI ARABIA | Valid |
| ETRIVEX 0.05% SHAMPOO | 0.05 % | Shampoo · Topical | 1 Bottle | SAR 60.55 | Generic · Prescription | GALDERMA | Valid |
| GAMAVATE 0.05% cream | 0.05 % | Cream · Topical | 1 Tube | SAR 8.95 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| GAMAVATE 0.05% ointment | 0.05 % | Ointment · Topical | 1 Tube | SAR 8.95 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| Glevate | 0.05 % | Cutaneous liquid · Topical | 1 Spray Pump | SAR 60.55 | Generic · Prescription | Glenmark Pharmaceuticals Limited | Valid |
| PROMAX 0.05% OINTMENT | 0.05 % | Ointment · Topical | 1 Tube | SAR 8.05 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| CLOBEDERM | 0.05 % | Cream · Topical | 1 Tube | SAR 6.10 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| CLOBEDERM | 0.05 % | Ointment · Topical | 1 Tube | SAR 3.70 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| CLOBEDERM | 0.05 % | Ointment · Topical | 1 Tube | SAR 3.95 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| CORTIMAX CREAM 0.05% W-W | 0.05 % | Cream · Topical | 1 Tube | SAR 6.35 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| CORTIMAX OINTMENT 0.05% W-W | 0.05 % | Ointment · Topical | 1 Tube | SAR 6.80 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| DECLOBAN OINTMENT | 0.05 % | Ointment · Topical | 1 Tube | SAR 7.50 | Generic · Prescription | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| DELOR 0.05% CREAM | 0.05 % | Cream · Topical | 1 Tube | SAR 5.35 | Generic · Prescription | Pharma International Co. | Withdrawn by MAH · Not Marketed |
| DELOR 0.05% OINTMENT | 0.05 % | Ointment · Topical | 1 Tube | SAR 5.35 | Generic · Prescription | Pharma International Co. | Withdrawn by MAH · Not Marketed |
| DERMAL 0.05% CREAM | 0.05 % | Cream · Topical | 1 Tube | SAR 7.05 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| DERMOVATE 0.05% SCALP APPLICATION | 0.05 % | Scalp solution · Topical | 1 Bottle | SAR 50.00 | NCE · Prescription | GLAXO SAUDI ARABIA | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANAL FISSURE; BEHCET DISEASE; ECZEMA; GRAFT VERSUS HOST DISEASE; HUMAN IMMUNODEFICIENCY VIRUS; LICHEN PLANUS; PEMPHIGOID; PEMPHIGUS; PSORIASIS; VITILIGO
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CLOBETASOL PROPIONATE | 0.05% | ointment · topical | COSETTE PHARMS NC | Prescription | 16 Feb 1994 |
| CLOBETASOL PROPIONATE | 0.05% | ointment · topical | FOUGERA PHARMS | Prescription | 23 Feb 1996 |
| CLOBETASOL PROPIONATE | 0.05% | cream · topical | SUN PHARMA CANADA | Prescription | 8 Jul 1996 |
| CLOBETASOL PROPIONATE | 0.05% | ointment · topical | SUN PHARMA CANADA | Prescription | 12 Jul 1996 |
| CLOBETASOL PROPIONATE | 0.05% | cream · topical | FOUGERA PHARMS INC | Prescription | 30 Sep 1996 |
| CLOBETASOL PROPIONATE | 0.05% | gel · topical | PADAGIS US | Prescription | 31 Oct 1997 |
| CLOBETASOL PROPIONATE | 0.05% | ointment · topical | AUROBINDO PHARMA USA | Prescription | 12 Aug 1998 |
| CLOBETASOL PROPIONATE | 0.05% | solution · topical | SUN PHARMA CANADA | Prescription | 16 Nov 1998 |
| CLOBETASOL PROPIONATE | 0.05% | solution · topical | FOUGERA PHARMS | Prescription | 8 Feb 1999 |
| CLOBETASOL PROPIONATE (EMOLLIENT) | 0.05% | cream · topical | FOUGERA PHARMS | Prescription | 26 May 1999 |
| CLOBETASOL PROPIONATE | 0.05% | gel · topical | SUN PHARMA CANADA | Prescription | 28 May 1999 |
| CLOBETASOL PROPIONATE | 0.05% | gel · topical | FOUGERA PHARMS | Prescription | 15 Feb 2000 |
| CLOBETASOL PROPIONATE (EMOLLIENT) | 0.05% | cream · topical | SUN PHARMA CANADA | Prescription | 17 May 2000 |
| CLOBETASOL PROPIONATE | 0.05% | cream · topical | AUROBINDO PHARMA USA | Prescription | 9 Feb 2001 |
| CLOBEX | 0.05% | lotion · topical | GALDERMA LABS LP | Prescription | 24 Jul 2003 |
| CLOBEX | 0.05% | shampoo · topical | GALDERMA LABS | Prescription | 5 Feb 2004 |
| CLOBETASOL PROPIONATE | 0.05% | solution · topical | ENCUBE | Prescription | 5 Aug 2005 |
| CLOBEX | 0.05% | spray · topical | GALDERMA LABS LP | Prescription | 27 Oct 2005 |
| CLOBETASOL PROPIONATE | 0.05% | aerosol, foam · topical | PADAGIS ISRAEL | Prescription | 10 Mar 2008 |
| CLOBETASOL PROPIONATE | 0.05% | lotion · topical | ACTAVIS MID ATLANTIC | Prescription | 4 Dec 2008 |
| CLOBETASOL PROPIONATE | 0.05% | lotion · topical | SUN PHARMA CANADA | Prescription | 2 Jul 2012 |
| CLOBETASOL PROPIONATE | 0.05% | shampoo · topical | PADAGIS ISRAEL | Prescription | 9 Aug 2012 |
| CLOBETASOL PROPIONATE | 0.05% | aerosol, foam · topical | PADAGIS ISRAEL | Prescription | 14 Aug 2012 |
| CLOBETASOL PROPIONATE | 0.05% | solution · topical | NOVEL LABS INC | Prescription | 23 Nov 2015 |
| CLOBETASOL PROPIONATE | 0.05% | spray · topical | ZYDUS PHARMS | Prescription | 16 Feb 2017 |
75 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CLOBEX SHAMPOO | 02256371 | 0.05 % | SHAMPOO · TOPICAL | GALDERMA CANADA INC. |
| CLOBEX SPRAY | 02299739 | 0.05 % / W/W | SPRAY · TOPICAL | GALDERMA CANADA INC. |
| DERMOVATE CREAM | 02213265 | 0.05 % | CREAM · TOPICAL | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| DERMOVATE OINTMENT | 02213273 | 0.05 % | OINTMENT · TOPICAL | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| DERMOVATE SCALP APPLICATION | 02213281 | 0.05 % | SOLUTION · TOPICAL | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| JAMP CLOBETASOL SPRAY | 02534665 | 0.05 % / W/W | SPRAY · TOPICAL | JAMP PHARMA CORPORATION |
| MYLAN-CLOBETASOL CREAM | 02024187 | 0.05 % | CREAM · TOPICAL | MYLAN PHARMACEUTICALS ULC |
| MYLAN-CLOBETASOL OINTMENT | 02026767 | 0.05 % | OINTMENT · TOPICAL | MYLAN PHARMACEUTICALS ULC |
| MYLAN-CLOBETASOL SCALP APPLICATION | 02216213 | 0.05 % | LOTION · TOPICAL | MYLAN PHARMACEUTICALS ULC |
| ODAN CLOBETASOL SPRAY | 02490706 | 0.05 % / W/W | SPRAY · TOPICAL | ODAN LABORATORIESLTD |
| REDDY-CLOBETASOL SHAMPOO | 02519437 | 0.05 % | SHAMPOO · TOPICAL | DR. REDDY'S LABORATORIES CANADA INC. |
| TARO-CLOBETASOL CREAM USP, 0.05% | 02245523 | 0.05 % | CREAM · TOPICAL | TARO PHARMACEUTICALS INC |
| TARO-CLOBETASOL OINTMENT USP, 0.05% | 02245524 | 0.05 % | OINTMENT · TOPICAL | TARO PHARMACEUTICALS INC |
| TARO-CLOBETASOL SHAMPOO | 02506203 | 0.05 % / W/W | SHAMPOO · TOPICAL | TARO PHARMACEUTICALS INC |
| TARO-CLOBETASOL SPRAY | 02489619 | 0.05 % / W/W | SPRAY · TOPICAL | TARO PHARMACEUTICALS INC |
| TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05% | 02245522 | 0.05 % | SOLUTION · TOPICAL | TARO PHARMACEUTICALS INC |
| TEVA-CLOBETASOL | 01910272 | 0.05 % | CREAM · TOPICAL | TEVA CANADA LIMITED |
| TEVA-CLOBETASOL | 01910280 | 0.05 % | OINTMENT · TOPICAL | TEVA CANADA LIMITED |
| TEVA-CLOBETASOL | 01910299 | 0.05 % | LOTION · TOPICAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CLOBETASOL 0.05% CREAM | $0.19302 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% CREAM | $0.16675 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% CREAM | $0.12164 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% CREAM | $0.14036 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% GEL | $0.86248 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% GEL | $0.47631 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% GEL | $0.46115 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% OINTMENT | $0.13828 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% OINTMENT | $0.15332 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% OINTMENT | $0.10833 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% OINTMENT | $0.11459 | per GM | 23 Sep 2026 |
| US NADAC | CLOBETASOL 0.05% SHAMPOO | $0.23313 | per ML | 23 Sep 2026 |
| NHS Drug Tariff | Clobetasol 0.05% cream | £2.69 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 0.05% cream | £7.90 | 100 gram | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 0.05% ointment | £2.69 | 30 gram | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 0.05% ointment | £7.90 | 100 gram | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 0.05% scalp application | £3.07 | 30 ml | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 0.05% scalp application | £10.42 | 100 ml | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 500micrograms/g foam | £11.06 | 100 gram | 1 Oct 2026 |
| NHS Drug Tariff | Clobetasol 500micrograms/g shampoo | £9.15 | 125 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 21 Dec 2018 CLOBEX — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 14 May 2018 OLUX E — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 25 Apr 2018 OLUX — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.